Sequential treatment of cancers using 6-thio-dg, checkpoint inhibitors and radiation therapy

AU2026206150A1Pending Publication Date: 2026-08-06BOARD OF RGT THE UNIV OF TEXAS SYST
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
BOARD OF RGT THE UNIV OF TEXAS SYST
Filing Date
2026-07-16
Publication Date
2026-08-06

Smart Images

  • Figure 00000070_0000
    Figure 00000070_0000
  • Figure 00000070_0001
    Figure 00000070_0001
  • Figure 00000071_0000
    Figure 00000071_0000
Patent Text Reader

Abstract

Abstract Disclosed herein are methods of treatments with a telomerase-mediated telomere-targeting drug, 6-thio-2 - deoxyguano sine (6-thio-dG), checkpoint inhibitors and / or radiation therapy for treating cancers, which leads to tumor regression in innate and adaptive immune-dependent manners in syngeneic and humanized mouse cancer models. Abstract
Need to check novelty before this filing date? Find Prior Art